GlassScriptPhysician profile
Himabindu Reddy
NPI 1659667160
$6,703.96
in general payments reported to CMS, 2019-2025
29 companies · $1,546 in 2025
The $1,546 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.19 · 2020: $94.04 · 2021: $56.85 · 2022: $2,843 · 2023: $1,045 · 2024: $1,100 · 2025: $1,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,317 · Education: $224 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,317.40 |
| Education | $223.99 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $1,340.91 | 2022 | |
| Harmony Biosciences LLC | $1,230.45 | 2022-2025 | Wakix |
| Intuitive Surgical, INC. | $1,028.98 | 2022 | |
| Jazz Pharmaceuticals INC. | $700.63 | 2020-2025 | |
| Glaxosmithkline, LLC. | $348.09 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Axsome Therapeutics, INC. | $275.72 | 2024-2025 | Sunosi |
| Ani Pharmaceuticals, INC. | $262.68 | 2023-2025 | Purified Cortrophin Gel |
| Astrazeneca Pharmaceuticals LP | $233.82 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Grifols USA, LLC | $168.53 | 2020-2025 | Prolastin-C Liquid |
| Vanda Pharmaceuticals INC. | $162.19 | 2022-2023 | Hetlioz |
| Actelion Pharmaceuticals US, INC. | $157.23 | 2022-2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.23 | 2021-2025 | Ofev, Jascayd |
| Inspire Medical Systems, INC. | $75.30 | 2023 | Inspire |
| Verona Pharma, INC. | $74.39 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $74.04 | 2025 | Zepbound |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $58.37 | 2023-2025 | |
| Genzyme Corporation | $55.30 | 2025 | |
| United Therapeutics Corporation | $53.65 | 2022-2023 | Tyvaso |
| 3b Medical, INC. | $52.72 | 2025 | Luna |
| Inogen, INC. | $52.40 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Avadel Cns Pharmaceuticals, LLC | $46.63 | 2024-2025 | Lumryz |
| Electromed, INC. | $28.19 | 2023-2024 | Smartvest |
| Advanced Respiratory, INC | $24.19 | 2020 | |
| Paratek Pharmaceuticals, INC. | $22.30 | 2024 | Nuzyra |
| Pfizer INC. | $17.41 | 2020 | |
| Eisai INC. | $17.20 | 2021 | |
| Philips North America LLC | $16.63 | 2024 | (Ak6) Vest Therapy |
| Hikma Pharmaceuticals USA | $15.96 | 2024 | Ryaltris |
| Teva Pharmaceuticals USA, INC. | $13.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Himabindu Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.